Allelic Variation of MHC Structure Alters Peptide Ligands to Induce Atypical Partial Agonistic CD8+ T Cell Function

T cell receptors recognize small changes in peptide ligands leading to different T cell responses. Here, we analyzed a panel of HLA-A2–Tax11-19 reactive T cell clones to examine how small allelic variations of MHC molecules could alter the functional outcome of antigen recognition. Similar to the effects induced by antigenic altered peptide ligands, weak or partial agonistic T cell functions were identified in individual T cell clones with the recognition of MHC-altered peptide ligands (MAPLs). Interestingly, one subtype of HLA-A2 molecules induced an unusual type of partial agonistic function; proliferation without cytotoxicity. Modeling of crystallographic data indicated that polymorphic amino acids in the HLA-A2 peptide binding groove, especially the D-pocket, were responsible for this partial agonism. Reciprocal mutations of the Tax peptide side chain engaging the D-pocket indeed restored the agonist functions of the MHC–peptide complex. Whereas early intracellular signaling events were not efficiently induced by these MAPLs, phosphorylated c-Jun slowly accumulated with sustained long-term expression. These data indicate that MAPLs can induce atypical partial agonistic T cell function through structural and biochemical mechanisms similar to altered peptide ligands.

[1]  S. Jameson,et al.  T-cell-receptor affinity and thymocyte positive selection , 1996, Nature.

[2]  J. Strominger,et al.  Alloreactivity studied with mutants of HLA-A2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[3]  B M Baker,et al.  Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. , 1999, Immunity.

[4]  L. Moretta,et al.  Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses. , 1998, Immunology today.

[5]  G. Freeman,et al.  Examination of CD8+ T Cell Function in Humans Using MHC Class I Tetramers: Similar Cytotoxicity but Variable Proliferation and Cytokine Production Among Different Clonal CD8+ T Cells Specific to a Single Viral Epitope , 2000, The Journal of Immunology.

[6]  P. Allen,et al.  Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. , 1991, Science.

[7]  J. Bluestone,et al.  Dissociation of Intracellular Signaling Pathways in Response to Partial Agonist Ligands of the T Cell Receptor , 1998, The Journal of experimental medicine.

[8]  H. Weiner,et al.  Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. , 1996, The Journal of clinical investigation.

[9]  P. Allen,et al.  Fidelity of T cell activation through multistep T cell receptor zeta phosphorylation. , 1998, Science.

[10]  L. Samelson,et al.  Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists , 1995, Science.

[11]  D. Nesic,et al.  Prevention of antigen-induced microtubule organizing center reorientation in cytotoxic T cells by modulation of protein kinase C activity. , 1998, International immunology.

[12]  V. Kuchroo,et al.  An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. , 1995, Immunity.

[13]  S. Jameson,et al.  The impact of duration versus extent of TCR occupancy on T cell activation: a revision of the kinetic proofreading model. , 2001, Immunity.

[14]  R W Chesnut,et al.  Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. , 1997, Immunity.

[15]  R. Germain,et al.  Dissociation of phosphoinositide hydrolysis and Ca2+ fluxes from the biological responses of a T-cell hybridoma , 1988, Nature.

[16]  G. Berke The binding and lysis of target cells by cytotoxic lymphocytes: molecular and cellular aspects. , 1994, Annual review of immunology.

[17]  A. Sette,et al.  Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. , 1995, Immunity.

[18]  P. Allen,et al.  Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. , 1993, Journal of immunology.

[19]  D. Margulies,et al.  Lack of strict correlation of functional sensitization with the apparent affinity of MHC/peptide complexes for the TCR. , 1995, Journal of immunology.

[20]  G Hermanson,et al.  Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. , 1995, Journal of immunology.

[21]  深浦彦彰 Induction of Circulating Myelin Basic Protein and Proteolipid Protein-specific Transforming-Growth Factor-β1-secreting Th3 T Cells by Oral Administration of Myelin in Multiple Sclerosis Patients(ミエリン蛋白を経口投与された多発性硬化症患者におけるミエリン塩基性蛋白およびプロテオリピッドプロテイン特異的TGF-β1分泌性Th3T細胞の促進) , 1997 .

[22]  H. Ploegh,et al.  Peptide antagonism and T cell receptor interactions with peptide-MHC complexes. , 1998, Immunity.

[23]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[24]  T. Lybrand,et al.  Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR. , 1998, Journal of immunology.

[25]  D. Wiley,et al.  Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.

[26]  P. Allen,et al.  Essential flexibility in the T-cell recognition of antigen , 1996, Nature.

[27]  Mike Carson,et al.  RIBBONS 2.0 , 1991 .

[28]  R. Germain,et al.  Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling , 1993, The Journal of experimental medicine.

[29]  Y. Chien,et al.  A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists. , 1996, Immunity.

[30]  D. Wiley,et al.  Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. , 1998, Immunity.

[31]  M. Rincón MAP-kinase signaling pathways in T cells. , 2001, Current opinion in immunology.

[32]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[33]  J. Frelinger,et al.  Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Esser,et al.  Distinct T cell receptor signaling requirements for perforin- or FasL- mediated cytotoxicity , 1996, The Journal of experimental medicine.

[35]  D. Wiley,et al.  The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 , 1993, Cell.

[36]  M. A. Saper,et al.  Specificity pockets for the side chains of peptide antigens in HLA-Aw68 , 1990, Nature.

[37]  A. Sette,et al.  Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells , 1994, Nature.

[38]  R. Germain,et al.  Relationships among TCR ligand potency, thresholds for effector function elicitation, and the quality of early signaling events in human T cells. , 1998, Journal of immunology.

[39]  Sarah Rowland-Jones,et al.  Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants , 1994, Nature.

[40]  T. McKeithan,et al.  Kinetic proofreading in T-cell receptor signal transduction. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Sette,et al.  Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[42]  M. Bevan,et al.  Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide , 1996, The Journal of experimental medicine.

[43]  D. Hafler,et al.  Conserved CDR3 Regions in T-Cell Receptor (TCR) CD8+T Cells That Recognize the Tax11-19/HLA-A*0201 Complex in a Subject Infected with Human T-Cell Leukemia Virus Type 1: Relationship of T-Cell Fine Specificity and Major Histocompatibility Complex/Peptide/TCR Crystal Structure , 2001, Journal of Virology.

[44]  A. Lanzavecchia,et al.  Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy , 1996, The Journal of experimental medicine.

[45]  M. Davis,et al.  Altered T cell receptor ligands trigger a subset of early T cell signals. , 1996, Immunity.

[46]  Partho Ghosh,et al.  Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 , 1996, Nature.